drugset / Trial / NCT00002036
Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)
Treatment
Summary
To investigate the potential benefit of providing passive immunity with hyperimmune anti-HIV human serum.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anti-HIV Immune Serum Globulin (Human) | Protein / enzyme biologic | — | — |